LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$97.5M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$67.1M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
+$66.3M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$56.3M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$52.4M |
Top Sells
| 1 |
Invesco BuyBack Achievers ETF
PKW
|
+$117M |
| 2 |
SPDR Gold Trust
GLD
|
+$51.3M |
| 3 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$40.8M |
| 4 |
SPDR S&P Homebuilders ETF
XHB
|
+$35.4M |
| 5 |
iShares MSCI Canada ETF
EWC
|
+$33.1M |
Sector Composition
| 1 | Financials | 3.29% |
| 2 | Technology | 3.19% |
| 3 | Healthcare | 3.03% |
| 4 | Industrials | 2.66% |
| 5 | Energy | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Vanguard Total International Stock ETF
VXUS
$103B
| $5.89M | 0.03% |
121,919
-27,085
| -18% | -$1.31M |
|
427
iShares Core Moderate Allocation ETF
AOM
$1.6B
| $5.89M | 0.03% |
167,419
+27,773
| +20% | +$977K |
|
428
Prospect Capital
PSEC
$1.29B
| $5.82M | 0.03% |
704,049
+439,608
| +166% | +$3.63M |
|
429
Exelon
EXC
$43.8B
| $5.79M | 0.03% |
219,091
-3,063
| -1% | -$81K |
|
430
EOG Resources
EOG
$65.7B
| $5.77M | 0.03% |
62,669
+12,768
| +26% | +$1.18M |
|
431
BlackRock Corporate High Yield Fund
HYT
$1.53B
| $5.75M | 0.03% |
504,276
+33,115
| +7% | +$378K |
|
432
iShares MSCI Pacific ex Japan ETF
EPP
$1.84B
| $5.75M | 0.03% |
130,732
-9,937
| -7% | -$437K |
|
433
iShares Global Healthcare ETF
IXJ
$3.83B
| $5.7M | 0.03% |
114,456
| – | – |
|
434
SPDR S&P 600 Small Cap Value ETF
SLYV
$4.04B
| $5.67M | 0.03% |
107,166
+16,152
| +18% | +$854K |
|
|
VQT
435
DELISTED
iPath S&P VEQTOR ETN
VQT
| $5.65M | 0.03% |
36,786
+1,890
| +5% | +$290K |
|
|
CSF
436
DELISTED
VictoryShares US Discovery Enhanced Volatility Wtd ETF
CSF
| $5.65M | 0.03% |
147,586
+114,220
| +342% | +$4.37M |
|
437
Schwab US Dividend Equity ETF
SCHD
$71.6B
| $5.62M | 0.03% |
423,285
+70,872
| +20% | +$941K |
|
438
SPDR S&P Aerospace & Defense ETF
XAR
$4B
| $5.6M | 0.03% |
102,578
+13,878
| +16% | +$758K |
|
439
Lowe's Companies
LOW
$149B
| $5.6M | 0.03% |
81,412
+3,572
| +5% | +$246K |
|
440
BlackRock Credit Allocation Income Trust
BTZ
$1.04B
| $5.6M | 0.03% |
433,331
+184,202
| +74% | +$2.38M |
|
441
Invesco National AMT-Free Municipal Bond ETF
PZA
$3.06B
| $5.6M | 0.03% |
220,356
+15,667
| +8% | +$398K |
|
442
WisdomTree US SmallCap Earnings Fund
EES
$631M
| $5.57M | 0.03% |
201,810
-6,849
| -3% | -$189K |
|
443
Cohen & Steers Infrastructure Fund
UTF
$2.52B
| $5.55M | 0.03% |
244,331
-3,712
| -1% | -$84.3K |
|
444
Vanguard Mega Cap Value ETF
MGV
$9.91B
| $5.55M | 0.03% |
91,405
+19,862
| +28% | +$1.21M |
|
445
Sysco
SYY
$38.3B
| $5.54M | 0.03% |
139,588
-11,718
| -8% | -$465K |
|
|
HTD
446
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$874M
| $5.53M | 0.03% |
248,314
+53,043
| +27% | +$1.18M |
|
447
TJX Companies
TJX
$156B
| $5.51M | 0.03% |
160,574
+10,988
| +7% | +$377K |
|
448
Trinity Industries
TRN
$2.28B
| $5.5M | 0.03% |
272,765
-97,895
| -26% | -$1.97M |
|
449
VanEck Intermediate Muni ETF
ITM
$1.97B
| $5.5M | 0.03% |
116,144
-33,826
| -23% | -$1.6M |
|
450
Regeneron Pharmaceuticals
REGN
$58.9B
| $5.5M | 0.03% |
13,397
+591
| +5% | +$242K |
|